@dr.ranywoo: What you should know: The official stance of the AAO and NANOS is that routine eye exams solely to assess NAION risk before starting a GLP-1 medication are not recommended, as current evidence does not support this practice. This includes screening for optic nerve findings such as crowded disc or “disc at risk”. #doctor #education #ophthalmologist #glp1 #vision